V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240012102 | 240008291 | 1.78 | null | Palliative (P) | 2013-05-10 | 2013-06-13 | Hydroxycarbamide | 01 | N | 240034151 | METHOTREXATE |
| 240012103 | 240014381 | 1.77 | 75.5 | Palliative (P) | 2018-05-19 | 2018-05-19 | BEAM | N | N | 240034153 | BEAM |
| 240012104 | 240008293 | 1.61 | 73 | Adjuvant (A) | 2014-10-09 | 2014-10-22 | BEAM | null | null | 240034163 | ABVD |
| 240012105 | 240008294 | 1.65 | 78.6 | Disease modification (D) | 2014-08-12 | 2014-10-10 | Trastuzumab Subcutaneous | N | Y | 240034163 | GEMCITABINE |
| 240012106 | 240008299 | null | 57.5 | Curative (C) | 2018-06-26 | 2018-06-26 | Methotrexate High Dose (3g/m2) | N | N | 240034176 | LENALIDOMIDE |
| 240012107 | 240012448 | 0 | 50.4 | Disease modification (D) | 2013-07-22 | 2013-08-01 | Methotrexate Intermed dose (1g/m2) | N | N | 240034177 | CYCLOPHOSPHAMIDE |
| 240012108 | 240008302 | 1.87 | 77.8 | Disease modification (D) | 2017-07-31 | 2017-08-01 | Bortezomib (weekly) | 02 | N | 240034188 | BENDAMUSTINE |
| 240012109 | 240008304 | 1.77 | 80.4 | Adjuvant (A) | 2016-10-11 | 2016-10-17 | Hydroxycarbamide | N | N | 240034188 | CISPLATIN + TOPOTECAN |
| 240012110 | 240015366 | null | 55 | Curative (C) | 2014-08-24 | 2014-08-26 | CARBOPLATIN + ETOPOSIDE | Y | N | 240034213 | CYCLOPHOSPHAMIDE |
| 240012111 | 240015366 | 1.75 | 80 | null | 2017-07-26 | 2017-08-10 | ABVD | N | N | 240034213 | METHOTREXATE |
| 240012112 | 240015366 | null | 80.1 | Palliative (P) | 2016-07-20 | 2018-06-07 | Chlorambucil | N | N | 240034213 | CHLORAMBUCIL |
| 240012113 | 240008305 | 1.69 | 78.9 | Disease modification (D) | 2015-08-05 | 2015-08-19 | Brentuximab | N | N | 240034227 | BRENTUXIMAB |
| 240012114 | 240008305 | 1.75 | null | Disease modification (D) | 2017-02-13 | 2017-02-26 | Cytarabine Low Dose | 02 | N | 240034227 | LENALIDOMIDE |
| 240012115 | 240008307 | null | 85.4 | Curative (C) | 2013-11-01 | 2013-11-01 | R Chlorambucil | N | N | 240034244 | CHLORAMBUCIL + RITUXIMAB |
| 240012116 | 240012451 | 1.75 | 88.2 | Palliative (P) | 2018-05-07 | 2018-07-07 | Cisplatin + Etoposide po | 02 | N | 240034254 | FCR |
| 240012117 | 240008310 | 1.57 | 43.6 | Palliative (P) | 2017-05-13 | 2017-05-21 | CYCLOPHOSPHAMIDE + RITUXIMAB | 99 | N | 240034260 | HYDROXYCARBAMIDE |
| 240012118 | 240008314 | 1.68 | 66.6 | Curative (C) | 2017-08-06 | 2017-08-06 | Bortezomib +/- Dexamethasone | N | N | 240034266 | CISPLATIN + TOPOTECAN |
| 240012119 | 240008315 | 1.6 | 124.4 | Palliative (P) | 2015-03-22 | 2015-03-24 | Brentuximab Vedotin | 2 | null | 240034268 | BRENTUXIMAB |
| 240012120 | 240008315 | 1.67 | 62.8 | Palliative (P) | 2019-02-23 | 2019-02-24 | CYCLOPHOSPHAMIDE + RITUXIMAB | 2 | N | 240034268 | CARBOPLATIN + ETOPOSIDE |
| 240012121 | 240014386 | 1.78 | 82.4 | Disease modification (D) | 2016-11-13 | 2016-11-14 | CARBOPLATIN + GEMCITABINE | N | N | 240034270 | TRASTUZUMAB |
| 240012122 | 240014386 | 1.6 | 47.9 | Disease modification (D) | 2013-11-25 | 2013-11-25 | LENALIDOMIDE | 2 | N | 240034270 | IBRUTINIB |
| 240012123 | 240008316 | 1.57 | null | Disease modification (D) | null | 2018-07-03 | Hydroxycarbamide | 2 | N | 240034288 | METHOTREXATE |
| 240012124 | 240008316 | 1.65 | 62.5 | Curative (C) | 2013-05-13 | 2013-05-13 | IBRUTINIB | 99 | N | 240034288 | HYDROXYCARBAMIDE |
| 240012125 | 240008318 | 1.54 | 76.6 | null | 2013-06-13 | 2013-07-15 | FLAG + Idarubicin | N | N | 240034291 | LEAM |
| 240012126 | 240015871 | 1.66 | null | Curative (C) | 2014-10-26 | 2014-11-17 | LENALIDOMIDE | null | null | 240034299 | CYTARABINE |
| 240012127 | 240015871 | 1.57 | 55.2 | Curative (C) | 2018-07-23 | 2018-07-23 | DHAP | N | N | 240034299 | BENDAMUSTINE |
| 240012128 | 240008319 | 0 | 78 | Palliative (P) | 2016-10-26 | 2016-10-27 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 2 | N | 240034311 | CISPLATIN + TOPOTECAN |
| 240012129 | 240008320 | 1.75 | 69 | Palliative (P) | 2015-05-04 | 2015-05-07 | Cisplatin + Topotecan | 02 | N | 240034321 | DA |
| 240012130 | 240014388 | 1.69 | 69.3 | Palliative (P) | 2016-08-24 | 2016-08-31 | ABVD | 2 | N | 240034324 | GEMCITABINE |
| 240012131 | 240015370 | null | 73 | Palliative (P) | 2015-05-11 | 2015-05-12 | METHOTREXATE | 2 | N | 240034327 | TRASTUZUMAB |
| 240012132 | 240008324 | 1.74 | 43.6 | Palliative (P) | 2016-08-29 | 2016-09-03 | GDP | Y | N | 240034327 | IBRUTINIB |
| 240012133 | 240008324 | null | null | null | 2013-09-18 | 2013-09-18 | CISPLATIN + ETOPOSIDE | N | N | 240034327 | BORTEZOMIB |
| 240012134 | 240008327 | 1.64 | 91.4 | Palliative (P) | 2016-11-26 | 2016-11-29 | BEAM | N | N | 240034332 | GDP |
| 240012135 | 240008330 | 0 | 76.6 | Palliative (P) | 2013-01-21 | 2013-08-08 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 240034346 | TRASTUZUMAB |
| 240012136 | 240015372 | 1.44 | null | Disease modification (D) | 2018-04-07 | 2018-04-22 | Brentuximab Vedotin | N | null | 240034348 | BRENTUXIMAB |
| 240012137 | 240008331 | null | 68.5 | Palliative (P) | 2017-07-04 | 2017-07-04 | Bendamustine + prednisolone | 02 | N | 240034356 | METHOTREXATE |
| 240012138 | 240008332 | null | 64.3 | Palliative (P) | null | 2015-06-14 | Methotrexate High Dose (3g/m2) | 2 | N | 240034356 | TRASTUZUMAB |
| 240012139 | 240015373 | 1.58 | null | Curative (C) | 2013-02-10 | 2013-07-02 | Methotrexate High Dose (3g/m2) | 02 | N | 240034370 | METHOTREXATE HIGH DOSE |
| 240012140 | 240015873 | 1.54 | 56.5 | Curative (C) | 2015-12-18 | 2015-12-20 | Cyclophosphamide oral | N | null | 240034371 | IBRUTINIB |
| 240012141 | 240016132 | null | 104.1 | Disease modification (D) | 2015-07-06 | 2015-07-06 | R Chlorambucil | 02 | N | 240034375 | CHLORAMBUCIL + RITUXIMAB |
| 240012142 | 240008333 | null | 49.4 | Curative (C) | 2014-04-30 | 2014-04-30 | Bortezomib (weekly) | N | N | 240034382 | LENALIDOMIDE |
| 240012143 | 240014393 | 1.71 | 64.9 | null | null | 2017-06-13 | Cytarabine Low Dose | N | N | 240034384 | CYTARABINE |
| 240012144 | 240008335 | 1.57 | 92.2 | Curative (C) | null | 2015-08-06 | BENDAMUSTINE | N | N | 240034384 | CISPLATIN + ETOPOSIDE |
| 240012145 | 240008336 | 1.73 | 60.8 | null | null | 2015-11-17 | BEAM | N | null | 240034406 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 240012146 | 240008337 | null | 113.9 | Curative (C) | 2017-05-13 | 2017-06-08 | Chlorambucil | N | N | 240034408 | CHLORAMBUCIL |
| 240012147 | 240012465 | 1.58 | 119 | Disease modification (D) | 2015-09-28 | 2015-11-18 | GDP | 02 | N | 240034409 | METHOTREXATE HIGH DOSE |
| 240012148 | 240012465 | 1.77 | 62.5 | Palliative (P) | 2017-12-24 | 2017-12-24 | Methotrexate High Dose (3g/m2) | 99 | N | 240034409 | LEAM |
| 240012149 | 240008340 | 1.74 | 90.5 | Neo-adjuvant (N) | null | 2016-08-02 | METHOTREXATE | N | N | 240034418 | BEAM |
| 240012150 | 240008341 | 1.6 | 66 | Curative (C) | 2013-05-16 | 2014-04-24 | Cisplatin + Topotecan | N | N | 240034422 | DA |
| 240012151 | 240008344 | 1.61 | 65.3 | Palliative (P) | 2015-04-18 | 2015-06-09 | Hydroxycarbamide | 02 | N | 240034422 | IBRUTINIB |